However, MOTS-c treatment markedly inhibited the expressions of CD11b and F4/80 in the tumor-bearing distal femora of BCP mice to a level comparable to that in BCP mice (P<0.01 for CD11b,P<0.05 for F4/80;Figure 5A,B,C,F). Here, ITGAM is linked to neoplasm.